Pharmacological activation of RXR improves insulin sensitivity and attenuates hyperglycemia, hypertriglyceridemia, hyperinsulinemia, weight gain, and food intake in diabetic and obese mouse models.11 Here, INS is linked to hypertriglyceridemia.